TheraRadar
← Back
Data updated: Mar 29, 2026

DEVA HOLDING AS

Infectious DiseaseOphthalmologyOncology
Generics

DEVA HOLDING AS is a generic drug manufacturer focused on Infectious Disease, Ophthalmology, Oncology.

2017
Since
11
Drugs
-
Trials
165
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

AMOXICILLIN AND CLAVULANATE POTASSIUM 2026-02-15
Labeling
LENALIDOMIDE 2026-02-02
AMOXICILLIN AND CLAVULANATE POTASSIUM 2026-01-30
Labeling
TEMOZOLOMIDE 2026-01-22
Labeling
TEMOZOLOMIDE 2026-01-22
Labeling
CYCLOSPORINE 2026-01-21
AMOXICILLIN AND CLAVULANATE POTASSIUM 2026-01-05
Labeling
ISOPROTERENOL HYDROCHLORIDE 2025-12-10
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 20%
1 drugs
Ophthalmology 20%
1 drugs
Oncology 20%
1 drugs
Gastroenterology 20%
1 drugs
Respiratory 20%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Oncology, Infectious Disease, Gastroenterology
Novartis big-pharma
Oncology, Ophthalmology, Respiratory
Baxter specialty
Infectious Disease, Oncology, Ophthalmology
AbbVie big-pharma
Oncology, Infectious Disease, Ophthalmology
Gilead Sciences biotech
Infectious Disease, Oncology, Gastroenterology, Respiratory